The global zinc sulphate market size stood at USD 1.82 billion in 2023. The market revenue is anticipated to rise from USD 1.91 billion in 2024 to USD 2.92 billion by 2032, registering a CAGR of 5.5% from 2024 to 2032.

The formula of zinc sulfate, ZnSO4, comprises numerous hydrate forms. It is used as an astringent in eye drops and lotions and to rectify zinc levels in the body. Zinc sulphate is essential in protein synthesis, enzyme function, and cell division. The increasing prominence of ZnSO4 in managing a strong immune system, wound healing methods, and complete cellular metabolism is fueling market expansion.

The COVID-19 pandemic adversely impacted the market due to supply chain interruptions and decreased product demand.

Fortune Business Insights™ shares this information in its report titled “Zinc Sulphate Market, 2024-2032.”

Segments

The Heptahydrate Segment Led the Market Due to Its Growing Usage in Manufacturing Rayon

In terms of type, the market is divided into heptahydrate, monohydrate, anhydrous, and hexahydrate. The heptahydrate segment led the global market due to its growing usage in the manufacturing of rayon (a type of fiber), as a mordant in dyeing procedures, and lithopone production. Zinc sulphate heptahydrate performs as colorless transparent crystals or white crystalline powder.

Growing Focus on Correcting Zinc Deficiency in Crops Fuels Adoption of Agrochemicals

By application, the market is segregated into agrochemicals, pharmaceuticals, chemical synthesis, synthetic fibers, water treatment, and others. Agrochemicals command the global market due to their growing usage in the agricultural industry to correct zinc deficiency in crops. The method of applying zinc sulphate in agrochemicals includes numerous ways, such as foliar sprays, soil application, and inclusion in fertilizers.

From the regional ground, the market is classified into Europe, Latin America, North America, Asia Pacific, and the Middle East & Africa.

Report Coverage

The report has studied the market in depth and underlined several crucial aspects and leading market participants. It provides important insights into the recent market trends and key industry developments. In addition to the factors mentioned above, the report covers many other factors that have helped the market grow.

Drivers and Restraints

Growing Focus on EV Adoption by Government and Constant Electrification of Cars Boosts Market Development

Zinc sulphate is highly preferred as a vital mineral for various medical applications in the pharmaceutical industry. This growth is driven by its essential role in human health, performing as a key component in protein synthesis, enzyme reactions, and immune function.

It is widely used in different pharmaceutical formulations, such as nutritional supplements, due to its effectiveness in treating and avoiding zinc deficiency. Along with its nutritional advantages, It is highly adopted in the formulation of tablets for cold therapy, signifying antiviral properties that decrease the duration and harshness of cold symptoms, propelling the zinc sulphate market growth.

In contrast, zinc sulphate manufacturing comprises energy-intensive processes. Consequently, instabilities in energy prices are impeding market growth.

Regional Insights

Rising Product Demand from Chemical Industries in India Boosted Market Growth in Asia Pacific

Asia Pacific commanded the global zinc sulphate market share due to rising product demand from chemical industries in India. Rapid industrialization and growing disposable incomes are also fueling market growth in the region.

The market in Europe is projected to witness steady growth in the coming years due to the increased demand for products from different sectors, including agrochemicals and chemical synthesis.

To get to know more about this market, please visit: https://www.fortunebusinessinsights.com/zinc-sulphate-market-110350 

Competitive Landscape

Top Players Focus on Expansion and Acquisition Tactics to Boost Their Market Shares

Top providers are focusing on investments to introduce innovative technologies to accelerate product value. Major players are implementing expansion and acquisition tactics to boost their market shares.

Key Industry Development

• August 2022: An honored business specializing in Complex Hospital Generics, Piramal Pharma's Critical Care division, launched the first generic Zinc Sulfate Injection to the U.S. market. This product has gained approval from the U.S. Food and Drug Administration. It has been selected as a Competitive Generic Therapy (CGT), a pathway intended to fuel market competition for drugs that are accessible from a single source.

List of Key Players Profiled in the Report:

• Balaji Chemicals (India)
• Changsha Haolin Chemicals Co., Ltd. (China)
• Bohigh Group (China)
• Old Bridge Minerals Inc. (U.S)
• Rongqing Chemical Co. Ltd (China)
• Clean Agro (India)
• Oasis Fine Chem (India)
• FUJI KASEI CO., LTD. (Japan)
• GRILLO-Werke AG (Germany)
• Prakash Chemicals (India)